Irbesartan, an angiotensin type 1 receptor inhibitor, regulates the vascular oxidative state in patients with coronary artery disease

Journal of the American College of Cardiology

Volumn 38, Issue 6, 2001, Pages 1662-1667

  Khan, Bobby V ^a,b   Navalkar, Sushant ^a,b   Khan, Qamar A ^a,b   Rahman, Syed T ^a,b   Parthasarathy, Sampath ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Building 2   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN I; ANGIOTENSIN RECEPTOR ANTAGONIST; IRBESARTAN; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE; PLACEBO; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; THIOBARBITURIC ACID;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFECT; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; MONOCYTE; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; ANTIHYPERTENSIVE AGENTS; BIPHENYL COMPOUNDS; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MACROPHAGE-1 ANTIGEN; MALE; MIDDLE AGED; OXIDATION-REDUCTION; SUPEROXIDES; TETRAZOLES; TREATMENT OUTCOME;

EID: 0035890275     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01615-1     Document Type: Article

References (39)

1. Role of oxidized low density lipoprotein in atherogenesis
2. Reversing endothelial dysfunction with angiotensin-converting enzyme inhibitors. A new trend?
3. Low-density lipoprotein receptor knockout mice exhibit exaggerated microvascular responses to inflammatory stimuli
4. Inability of plasma high-density lipoproteins to inhibit cell adhesion molecule expression in human coronary artery endothelial cells
5. Macrophages and atherosclerotic plaque stability
6. Effect of native and oxidized low-density lipoprotein on endothelial nitric oxide and superoxide production: Key role of L-arginine availability
7. Autoantibodies against oxidized LDL. A potential marker for atherosclerosis
8. Autoantibody titers to oxidized low-density lipoprotein in patients with coronary, atherosclerosis
9. A randomized placebo-controlled, double-blind study, of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension
10. 1 receptor antagonist: A review of its efficacy and safety in essential hypertension
11. Randomized trial of losartan versus captopril in patients over 65 with heart failure
12. 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes
13. Endothelium-derived relaxing factors and converting-enzyme inhibition
14. Role of bradykinin in mediating vascular effects of angiotensin converting enzyme inhibitors in humans
15. Bradykinin and the therapeutic actions of angiotensin converting enzyme inhibitors
16. 1 receptor antagonist, reduces markers of inflammation in patients with early atherosclerosis
17. Angiotensin II stimulates macrophage-mediated oxidation of low-density lipoprotein
18. Effects of in vitro addition of captopril on copper-induced low density lipoprotein oxidation
19. Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia
20. Neutrophil superoxide anion-generating capacity, endothelial function and oxidative stress in chronic heart failure: Effects of short- and long-term vitamin C therapy
21. Lucigenin chemiluminescence in the assessment of neutrophil superoxide production
22. Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells
23. Selective inhibition of cytosolic phospholipase A2 in activated human monocytes. Regulation of superoxide anion production and low density lipoprotein oxidation
24. Rapid, sensitive, and specific thiobarbituric acid method for measuring lipid peroxidation in animal tissue, food, and feedstuff samples
25. Angiotensin receptors
26. Angiotensin II receptor blockade and end-organ protection
27. Hypertension control: Multifactorial contributions
28. Phagocytic activity in blood of dogs with chronic heart failure
29. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation
30. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells
31. Vitamins C and E inhibit superoxide production in the pig coronary artery
32. Hypercholesterolemia increases endothelial superoxide anion production
33. Cardiac and vascular effects of long-term losartan treatment in stroke-prone spontaneously hypertensive rats
34. 2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism
35. Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human heart
36. 2 receptors in the acute phase of myocardial infarction
37. 2 receptor medicates inhibition of cell proliferation in coronary endothelial cells
38. Time course and extent of angiotensin II antagonism after irbesartan, losartan, and valsartan in humans assessed by angiotensin II dose response and radioligand receptor assay
39. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients